USPTO 2015–2025 USPTO PatentsView US Corporation

HighRes Biosolutions, Inc.

USPTO PatentsView assignee record - 25 granted patents across 9 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Highres ranks #12,041 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 9 technology areas.

#12,041
of 49,997 US assignees by volume
Top 28%
by Innovation Score (43.3/100)
24.6
avg claims per patent
+220%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12041 · US Corporation #12,041 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,041/49,997
  • PHOTO-FINISH Hemanext
  • CPC-NARROW G01N · 9 areas
  • INNOV-PAR 43.3/100
  • CLAIMS-DENSE 24.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +220% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hemanext Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Highres’s 43.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Highres

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Highres's Innovation Score is 43.3/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Highres?

Each dot is one of Highres’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Highres’s own 24.6 claims/patent is ABOVE the 18.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Highres vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 51015202530 Granted patents (volume) Avg claims / patent Hemanext Inc. - 25, 16.36HemanextHensley Industries, Inc. - 25, 18.4Hensley IndustriesHermes Innovations, LLC - 25, 19.44Hermes InnovationsHiddenLayer, Inc. - 25, 24.2HiddenlayerHomewerks Worldwide, LLC - 25, 7.84Homewerks Worldwi…Honeycomb Battery Company - 25, 19.96Honeycomb BatteryHuber Engineered Woods LLC - 25, 17.92Huber Engineered…Huron Technologies International Inc. - 25, 22.72Huron Internation…HighRes Biosolutions, Inc. - 25, 24.6Highres Biosoluti…
Highres vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Highres's grants concentrate

HighRes Biosolutions, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 80% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2016. By volume, Highres sits between Hemanext Inc. and Huron Technologies International Inc..

Highres's three-year grant acceleration

HighRes Biosolutions, Inc. shows 9 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at HighRes's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows HighRes holds 25 patents at rank #12,044, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near HighRes

By rank, the assignees closest to #12,044 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in HighRes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for HighRes, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), HighRes ranks #754 of 7,863 assignees by patent count in that subclass.

Highres's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201620172018201920202021202320242025 4
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
HighRes Biosolutions, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 4.0%
2017 1 4.0%
2018 1 4.0%
2019 2 8.0%
2020 2 8.0%
2021 5 20.0%
2023 5 20.0%
2024 4 16.0%
2025partial year 4 16.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

HighRes Biosolutions, Inc.'s patent record in context - here's where to go next.

  • HighRes Biosolutions, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 80% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #12,041 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare HighRes Biosolutions, Inc. against Hemanext Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.